Searched for
NATCO PHARMA SHARE
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Ahead of Market: 10 things that will decide stock market action on TuesdayBenchmark indices Sensex and Nifty fell for a fourth straight session amid elevated crude oil prices, geopolitical tensions and persistent ...
- Ahead of Market: 10 things that will decide stock market action on MondayIndian equity markets ended sharply lower on May 29 amid broad-based selling, MSCI-driven flows and rising volatility. Technical indicators...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Stock Radar: Natco Pharma stock shows rounding bottom formation; should you buy the stock for long term?Natco Pharma is trading above the neckline of a rounding bottom formation, suggesting a bullish outlook. Experts recommend buying for a tar...
- Natco Pharma shares drop over 5% after previous day’s double-digit gainsNatco Pharma shares fell as investors booked profits after a sharp rally in the previous session. The stock has been volatile this week, sl...
- Natco Pharma shares jump over 5% after three-day slumpNatco Pharma shares surged on Wednesday, bouncing back from a three-day decline that followed a US FDA inspection of its API manufacturing ...
- Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock IngramNatco’s proposed all-cash deal to acquire nearly 36% of AIHL from minority shareholders is aimed at expanding its presence in South Africa,...
- Stock Radar: Natco Pharma stock showing signs of momentum after falling over 30% from highs – what should investors do?Natco Pharma Ltd, a player in the pharma industry, has exhibited a bullish breakout from an Ascending Triangle pattern, hinting at potentia...
- NATCO Pharma shares plunge 20% after Q3 profit decline 37% YoY to Rs 132 croreNATCO Pharma faced a sharp decline, with a 37.75% drop in net profit in Q3 to Rs 132.4 crore due to lower formulation exports. Despite a ri...
- Accumulate Natco Pharma, target price Rs 1116: Geojit Financial ServicesNatco Pharma, incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 17460.53 crore) operating in pharmaceuticals s...
- Natco Pharma approves Rs 210 cr-share buyback; stock risesThe buyback proposal will not exceed the maximum size, which represents 5.13% and 5.04% of the aggregate of the total paid-up capital and f...
- Midcap pharma stock rises over 4% on share buyback planNatco Pharma has a market cap of Rs 10,367 crore as of March 3, 2023. From its 52-week high of Rs 920, the stock is trading 38% lower at Rs...
- Natco Pharma rises 4% on receiving court order to launch ChlorantraniliproleNatco is the first company in India to have received its registration approval given by the Central Insecticide Board & Registration Commit...
- Natco Pharma shares hit upper circuit. Here's whyThe Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.
Load More
